The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration
Open accessAbstract
Neuroinflammatory response is primarily a protective mechanism in the brain. However, excessive and chronic inflammatory responses can lead to deleterious effects involving immune cells, brain cells and signaling molecules. Neuroinflammation induces and accelerates pathogenesis of Parkinson's disease (PD), Alzheimer's disease (AD) and Multiple sclerosis (MS). Neuroinflammatory pathways are indicated as novel therapeutic targets for these diseases. Mast cells are immune cells of hematopoietic origin that regulate inflammation and upon activation release many proinflammatory mediators in systemic and central nervous system (CNS) inflammatory conditions. In addition, inflammatory mediators released from activated glial cells induce neurodegeneration in the brain. Systemic inflammation-derived proinflammatory cytokines/chemokines and other factors cause a breach in the blood brain-barrier (BBB) thereby allowing for the entry of immune/inflammatory cells including mast cell progenitors, mast cells and proinflammatory cytokines and chemokines into the brain. These peripheral-derived factors and intrinsically generated cytokines/chemokines, α-synuclein, corticotropin-releasing hormone (CRH), substance P (SP), beta amyloid 1-42 (Aβ1-42) peptide and amyloid precursor proteins can activate glial cells, T-cells and mast cells in the brain can induce additional release of inflammatory and neurotoxic molecules contributing to chronic neuroinflammation and neuronal death. The glia maturation factor (GMF), a proinflammatory protein discovered in our laboratory released from glia, activates mast cells to release inflammatory cytokines and chemokines. Chronic increase in the proinflammatory mediators induces neurotoxic Aβ and plaque formation in AD brains and neurodegeneration in PD brains. Glial cells, mast cells and T-cells can reactivate each other in neuroinflammatory conditions in the brain and augment neuroinflammation. Further, inflammatory mediators from the brain can also enter into the peripheral system through defective BBB, recruit immune cells into the brain, and exacerbate neuroinflammation. We suggest that mast cell-associated inflammatory mediators from systemic inflammation and brain could augment neuroinflammation and neurodegeneration in the brain. This review article addresses the role of some atypical inflammatory mediators that are associated with mast cell inflammation and their activation of glial cells to induce neurodegeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–211 of 211
Neurochemical and behavioral responses to inflammatory immune stressors
Anisman, H. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s26 · Cited by 22
The Role of Mast Cells in Intracerebral Hemorrhage
Yehya, M., & Torbey, M. (2017) · Neurocritical Care · doi:10.1007/s12028-017-0416-5 · Cited by 22
A case of early onset Parkinson's disease after major stress
Zheng, Z. S., Zou, K., Guo, W., Tang, G., & Zheng, B. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s48455 · Cited by 21
Perry, V. H. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0003-2015 · Cited by 21
Therapeutic potential of some stress mediators in early Alzheimer's disease
Pardon, M. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.09.006 · Cited by 19
Aheng, C., Ly, N. Y., Kelly, M., Ibrahim, S. M., Ricquier, D., Alves‐Guerra, M., & Miroux, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022841 · Cited by 16
Neurochemical and behavioral responses to inflammatory immune stressors
Gibb, J. (2009) · Frontiers in Bioscience-Elite · doi:10.2741/e26 · Cited by 12
Park, H., Park, M.-J., & Kwon, M. (2016) · International Neurourology Journal · doi:10.5213/inj.1632614.307 · Cited by 12
Imai, R., Asai, K., Hanai, J., & Takenaka, M. (2015) · Aging · doi:10.18632/aging.100779 · Cited by 11
Mast Cell Regulation of the Immune Response
Ryan, J. J., Morales, J. K., Falanga, Y. T., Fernando, J. F. A., & Macey, M. (2009) · World Allergy Organization Journal · doi:10.1097/wox.0b013e3181c2a95e · Cited by 10
Neuroimmune interactions: astrocytes
Visan, I. (2017) · Nature Immunology · doi:10.1038/ni.3700 · Cited by 4
Cited by
The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates
Franceschi, C., Garagnani, P., Morsiani, C., Conte, M., Santoro, A., Grignolio, A., Monti, D., Capri, M., & Salvioli, S. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00061 · Cited by 945
Adamu, A., Li, S., Gao, F., & Xue, G. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1347987 · Cited by 564
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00072 · Cited by 457
Zou, W., Pu, T., Feng, W., Lu, M., Zheng, Y., Du, R., Xiao, M., & Hu, G. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0147-y · Cited by 396
Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review
Sun, B., Wu, L., Wu, Y., Zhang, C., Qin, L., Hayashi, M., Kudo, M., Gao, M., & Liu, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.568032 · Cited by 353
Metadata
- Authors
- Kempuraj, D., Thangavel, R., Selvakumar, G. P., Zaheer, S., Ahmed, M. E., Raikwar, S. P., Zahoor, H., Saeed, D., Natteru, P. A., Iyer, S., & Zaheer, A.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-07-24
- Volume
- 11
- Pages
- 216-216
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2738410425
- Cited by
- 365
- References
- 211
- FWCI
- 13.20
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.